keyword
https://read.qxmd.com/read/38630540/impact-of-smoking-status-on-clinical-outcomes-in-patients-with-metastatic-renal-cell-carcinoma-treated-with-first-line-immune-checkpoint-inhibitor-based-regimens
#21
JOURNAL ARTICLE
Eddy Saad, Georges Gebrael, Karl Semaan, Marc Eid, Renée Maria Saliby, Chris Labaki, Nicolas Sayegh, J Connor Wells, Kosuke Takemura, Matthew Scott Ernst, Audreylie Lemelin, Naveen S Basappa, Lori A Wood, Thomas Powles, D Scott Ernst, Aly-Khan A Lalani, Neeraj Agarwal, Wanling Xie, Daniel Y C Heng, Toni K Choueiri
BACKGROUND: Current tobacco smoking is independently associated with decreased overall survival (OS) among patients with metastatic renal cell carcinoma (mRCC) treated with targeted monotherapy (VEGF-TKI). Herein, we assess the influence of smoking status on the outcomes of patients with mRCC treated with the current first-line standard of care of immune checkpoint inhibitor (ICI)-based regimens. MATERIALS AND METHODS: Real-world data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) were collected retrospectively...
April 17, 2024: Oncologist
https://read.qxmd.com/read/38630538/evolving-assessment-pathways-for-precision-oncology-medicines-to-improve-patient-access-a-tumor-agnostic-lens
#22
JOURNAL ARTICLE
Priscila Radu, Gayathri Kumar, Amanda Cole, Aikaterini Fameli, Mark Guthrie, Lieven Annemans, Jan Geissler, Antoine Italiano, Brian O'Rourke, Entela Xoxi, Lotte Steuten
BACKGROUND: Genomic and molecular alterations are increasingly important in cancer diagnosis, and scientific advances are opening new treatment avenues. Precision oncology (PO) uses a patient's genomic profile to determine optimal treatment, promising fewer side effects and higher success rates. Within PO, tumor-agnostic (TA) therapies target genomic alterations irrespective of tumor location. However, traditional value frameworks and approval pathways pose challenges which may limit patient access to PO therapies...
April 17, 2024: Oncologist
https://read.qxmd.com/read/38630498/advances-in-rapid-point-of-care-virus-testing
#23
REVIEW
Yu-Peng Zhang, Jin-Wei Bu, Ru-Xin Shu, Shu-Lin Liu
Outbreaks of viral diseases seriously jeopardize people's health and cause huge economic losses. At the same time, virology provides a new perspective for biology, molecular biology and cancer research, and it is important to study the discovered viruses with potential applications. Therefore, the development of immediate and rapid viral detection methods for the prevention and treatment of viral diseases as well as the study of viruses has attracted extensive attention from scientists. With the continuous progress of science and technology, especially in the field of bioanalysis, a series of new detection techniques have been applied to the on-site rapid detection of viruses, which has become a powerful approach for human beings to fight against viruses...
April 17, 2024: Analyst
https://read.qxmd.com/read/38630478/immune-checkpoint-inhibitor-use-during-pregnancy-and-outcomes-in-pregnant-individuals-and-newborns
#24
JOURNAL ARTICLE
Paul Gougis, Anne-Sophie Hamy, Floriane Jochum, Kevin Bihan, Marie Carbonnel, Joe-Elie Salem, Elise Dumas, Rayan Kabirian, Beatriz Grandal, Solenn Barraud, Florence Coussy, Judicael Hotton, Raphaelle Savarino, Aurélien Marabelle, Jacques Cadranel, Jean-Philippe Spano, Enora Laas, Fabien Reyal, Baptiste Abbar
IMPORTANCE: With the widespread use of immune checkpoint inhibitors (ICIs), concerns about their pregnancy outcomes through maternal exposure have emerged, and clinical comparative data are lacking. OBJECTIVE: To assess the risk of pregnancy-, fetal-, and/or newborn-related adverse outcomes associated with exposure to ICIs compared with exposure to other anticancer agents. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, all reports mentioning a pregnancy-related condition and an antineoplastic agent (Anatomical Therapeutic Chemical classification group L01) used for a cancer indication registered in the World Health Organization international pharmacovigilance database VigiBase up to June 26, 2022, were extracted...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38630475/unmet-needs-quality-of-life-and-financial-toxicity-among-survivors-of-lung-cancer
#25
JOURNAL ARTICLE
Melinda L Hsu, Mary C Boulanger, Sarah Olson, Cyd Eaton, Laura Prichett, Matthew Guo, Mattea Miller, Julie Brahmer, Patrick M Forde, Kristen A Marrone, Michelle Turner, Josephine L Feliciano
IMPORTANCE: Despite a growing population of survivors of lung cancer, there is limited understanding of the survivorship journey. Survivors of lung cancer experience unmet physical, social, emotional, and medical needs regardless of stage at diagnosis or treatment modalities. OBJECTIVE: To investigate the association of unmet needs with quality of life (QOL) and financial toxicity (FT) among survivors of lung cancer. DESIGN, SETTING, AND PARTICIPANTS: This survey study was conducted at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center thoracic oncology clinics between December 1, 2020, and September 30, 2021, to assess needs (physical, social, emotional, and medical), QOL, and FT among survivors of lung cancer...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38630468/design-synthesis-and-mechanistic-studies-of-r-3-amino-5-5-difluorocyclohex-1-ene-1-carboxylic-acid-as-an-inactivator-of-human-ornithine-aminotransferase
#26
JOURNAL ARTICLE
Allison N Devitt, Abigail L Vargas, Wei Zhu, Benjamin James Des Soye, Fatma Ayaloglu Butun, Tyler Alt, Nicholas Kaley, Glaucio M Ferreira, Graham Moran, Neil L Kelleher, Dali Liu, Richard B Silverman
Human ornithine aminotransferase ( h OAT), a pyridoxal 5'-phosphate (PLP)-dependent enzyme, has been shown to play an essential role in the metabolic reprogramming and progression of hepatocellular carcinoma (HCC). HCC accounts for approximately 75% of primary liver cancers and is within the top three causes of cancer death worldwide. As a result of treatment limitations, the overall 5-year survival rate for all patients with HCC is under 20%. The prevalence of HCC necessitates continued development of novel and effective treatment methods...
April 17, 2024: ACS Chemical Biology
https://read.qxmd.com/read/38630388/national-trends-in-the-treatment-of-adult-diffuse-midline-gliomas-a-rare-clinical-scenario
#27
JOURNAL ARTICLE
Jay Desai, Sujay Rajkumar, Matthew J Shepard, John Herbst, Stephen M Karlovits, Shakir Hasan, Zachary D Horne, Rodney E Wegner
PURPOSE: Diffuse midline gliomas (DMG) include all midline gliomas with a point mutation to the histone H3 gene resulting in the substitution of a lysine with a methionine (K27M). These tumors are classified as World Health Organization grade 4 with a mean survival between 9- and 19-months following diagnosis. There is currently no standard of care for DMG, and palliative radiation therapy has been proven to only extend survival by months. Our current study aims to report current treatment trends and predictors of the overall survival of DMG...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38630386/improved-outcomes-for-triple-negative-breast-cancer-brain-metastases-patients-after-stereotactic-radiosurgery-and-new-systemic-approaches
#28
JOURNAL ARTICLE
Elad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, Sylvia Adams, Brandon Santhumayor, Ying Meng, Zane Schnurman, Bernadine R Donahue, Kenneth Bernstein, Cordelia Orillac, Rishitha Bollam, Maryann J Kwa, Marleen Meyers, Ruth Oratz, Yelena Novik, Joshua S Silverman, David H Harter, John G Golfinos, Douglas Kondziolka
PURPOSE: Although ongoing studies are assessing the efficacy of new systemic therapies for patients with triple negative breast cancer (TNBC), the overwhelming majority have excluded patients with brain metastases (BM). Therefore, we aim to characterize systemic therapies and outcomes in a cohort of patients with TNBC and BM managed with stereotactic radiosurgery (SRS) and delineate predictors of increased survival. METHODS: We used our prospective patient registry to evaluate data from 2012 to 2023...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38630383/new-therapeutic-target-molecules-for-gastric-and-gastroesophageal-junction-cancer
#29
REVIEW
Hisato Kawakami
Molecularly targeted therapy for receptor tyrosine kinases (RTKs) has faced limitations in gastric and gastroesophageal junction (G/GEJ) cancer except for HER2-targeted agents, possibly due to inappropriate assay selection that has hindered identification of sensitive patients, in addition to coexisting genetic abnormalities as well as intratumoral heterogeneity. Immunohistochemistry of RTKs has, thus, proved largely unsuccessful for patient selection, and detection of RTK gene amplification as a true oncogenic driver is problematic given the small numbers of affected individuals...
April 17, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38630370/aortoesophageal-fistula-due-to-esophageal-cancer-a-case-report-of-successful-management
#30
JOURNAL ARTICLE
Kohei Saisho, Naoki Mori, Masashi Nakagawa, Eiji Nakamura, Yu Tanaka, Hideaki Kaku, Yuya Tanaka, Taro Isobe, Hiroyuki Otsuka, Tomoya Sudo, Hisamune Sakai, Nobuya Ishibashi, Toru Hisaka, Eiki Tayama, Fumihiko Fujita
BACKGROUND: Aortoesophageal fistula (AEF) is a rare but potentially life-threatening condition. The best treatment for the AEF due to esophageal carcinoma is still unresolved. Here, we report a rare case of AEF caused by esophageal cancer, that was successfully treated with emergency thoracic endovascular aortic repair (TEVAR), followed by esophagectomy and gastric tube reconstruction. CASE PRESENTATION: A 64-year-old man presented with loss of consciousness and hypotension during chemoradiotherapy for advanced esophageal cancer...
April 17, 2024: Surgical Case Reports
https://read.qxmd.com/read/38630355/activation-of-ctu2-expression-by-lxr-promotes-the-development-of-hepatocellular-carcinoma
#31
JOURNAL ARTICLE
Chao Xue, Zhuo Wei, Ye Zhang, Ying Liu, Shuang Zhang, Qi Li, Ke Feng, Xiaoxiao Yang, Guangqing Liu, Yuanli Chen, Xiaoju Li, Zhi Yao, Jihong Han, Yajun Duan
Cytosolic thiouridylase 2 (CTU2) is an enzyme modifying transfer RNAs post-transcriptionally, which has been implicated in breast cancer and melanoma development. And we found CTU2 participated in hepatocellular carcinoma (HCC) progression here. HepG2 cells as well as xenograft nude mice model were employed to investigate the role of CTU2 in HCC development in vitro and in vivo respectively. Further, we defined CTU2 as a Liver X receptor (LXR) targeted gene, with a typical LXR element in the CTU2 promoter. CTU2 expression was activated by LXR agonist and depressed by LXR knockout...
April 17, 2024: Cell Biology and Toxicology
https://read.qxmd.com/read/38630354/oculomics-a-crusade-against-the-four-horsemen-of-chronic-disease
#32
REVIEW
Emily J Patterson, Alistair D Bounds, Siegfried K Wagner, Richard Kadri-Langford, Robin Taylor, Dan Daly
Chronic, non-communicable diseases present a major barrier to living a long and healthy life. In many cases, early diagnosis can facilitate prevention, monitoring, and treatment efforts, improving patient outcomes. There is therefore a critical need to make screening techniques as accessible, unintimidating, and cost-effective as possible. The association between ocular biomarkers and systemic health and disease (oculomics) presents an attractive opportunity for detection of systemic diseases, as ophthalmic techniques are often relatively low-cost, fast, and non-invasive...
April 17, 2024: Ophthalmology and Therapy
https://read.qxmd.com/read/38630333/trends-in-ototoxicity-monitoring-among-cisplatin-treated-patients-with-cancer
#33
JOURNAL ARTICLE
David S Lee, Emma Y Travis, Susan K Wong, Marie-Ange Munyemana, Lauren Mueller, Cathryn Collopy Rowling, Jason T Rich, Patrik Pipkorn, Sidharth V Puram, Ryan S Jackson, Douglas R Adkins, Peter Oppelt, Wade L Thorstad, Cameron C Wick, Jose P Zevallos, Kate McClannahan, Angela L Mazul
PURPOSE: This study aims to characterize patterns in ototoxicity monitoring and identify potential barriers to audiologic follow-up. METHODS: We performed a single-institution retrospective cohort study on adult (≥ 18 years old) cancer patients treated with cisplatin from January 2014 to September 2021. Our primary outcomes were rates of baseline and post-treatment audiograms at the following time points: 3, 6, 12, and greater than 12 months...
April 17, 2024: Journal of Cancer Survivorship: Research and Practice
https://read.qxmd.com/read/38630332/attitudes-of-people-diagnosed-with-cancer-and-cancer-care-providers-towards-use-of-nicotine-vaping-products-in-high-income-countries-a-scoping-review
#34
REVIEW
Lavender A Otieno, Jeffin Baiju, Joshua Trigg
PURPOSE: To investigate the attitudes, beliefs and perceptions of people diagnosed with cancer and health practitioners on use of nicotine vaping products. METHODS: Scopus and OVID Medline were searched for papers published between 2013 and 2023. Two authors independently selected the studies and extracted data, with conflicts resolved through discussion. Nine studies were selected for further synthesis. Reporting follows the PRISMA Scoping Reviews checklist. RESULTS: E-cigarettes were commonly perceived as less harmful compared to conventional cigarettes and less detrimental to cancer treatment effectiveness among people with a current or previous cancer diagnosis...
April 17, 2024: Journal of Cancer Survivorship: Research and Practice
https://read.qxmd.com/read/38630304/tlr5-agonist-in-combination-with-anti-pd-1-treatment-enhances-anti-tumor-effect-through-m1-m2-macrophage-polarization-shift-and-cd8-t-cell-priming
#35
JOURNAL ARTICLE
Junseok Lee, Keon-Il Im, Sojin Gil, Hyemin Na, Gi-June Min, Nayoun Kim, Seok-Goo Cho
Immune checkpoint inhibitors have revolutionized anti-tumor therapy, notably improving treatment responses in various tumors. However, many patients remain non-responsive and do not experience benefits. Given that Toll-like receptors (TLRs) can counteract tumor immune tolerance by stimulating both innate and adaptive immune responses, TLR agonists are being explored as potential immune adjuvants for cancer treatment. In this study, we assessed the potential of enhancing the efficacy of immune checkpoint inhibitors by activating innate immunity with a TLR5 agonist...
April 17, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38630197/the-emerging-emetogenicity-of-trifluridine-tipiracil-tas%C3%A2-102-from-patient-self-reporting-a-multicenter-prospective-observational-study
#36
MULTICENTER STUDY
Hironori Fujii, Masami Tsuchiya, Daichi Watanabe, Ryo Otsuka, Daisuke Hirate, Katsuyuki Takahashi, Makiko Go, Toshihiro Kudo, Kazuhiro Shimomura, Yosuke Ando, Shinya Tani, Takao Takahashi, Katsuhisa Hayashi, Miki Chin, Naomi Matsunami, Masaya Takahashi, Akiko Hasegawa, Takashi Uchida, Hironobu Hashimoto, Akiko Kubo, Nobuhisa Matsuhashi, Akio Suzuki, Junichi Nishimura, Naoki Inui, Hirotoshi Iihara
BACKGROUND: Trifluridine/tipiracil (TAS-102) is an oral anticancer drug with adequate efficacy in unresectable colorectal cancer, but frequently also induces chemotherapy-induced nausea and vomiting (CINV). To investigate the occurrence of CINV and antiemetic therapy in patients with colorectal cancer treated with TAS-102 (JASCC-CINV 2001). METHODS: We conducted a multicenter, prospective, observational study in patients with colorectal cancer who received TAS-102 without dose reduction for the first time...
April 17, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38630184/identification-of-small-molecule-inhibitors-against-lin28-let-7-to-suppress-tumor-progression-and-its-alleviation-role-in-lin28-dependent-glucose-metabolism
#37
JOURNAL ARTICLE
Rachanaa Raja, Rajamanikandan Sundararaj, Ruckmani Kandasamy
The reciprocal suppression of an RNA-binding protein LIN28 (human abnormal cell lineage 28) and miRNA Let-7 (Lethal 7) is considered to have a prime role in hepatocellular carcinoma (HCC). Though targeting this inhibition interaction is effective for therapeutics, it causes other unfavorable effects on glucose metabolism and increased insulin resistance. Hence, this study aims to identify small molecules targeting Lin28/let-7 interaction along with additional potency to improve insulin sensitivity. Of 22,14,996 small molecules screened by high throughput virtual screening, 6 molecules, namely 41354, 1558, 12437, 23837, 15710, and 8319 were able to block the LIN28 interaction with let-7 and increase the insulin sensitivity via interacting with PPARγ (peroxisome proliferator-activated receptors γ)...
April 17, 2024: Medical Oncology
https://read.qxmd.com/read/38630183/evodiamine-potentiates-cisplatin-induced-cell-death-and-overcomes-cisplatin-resistance-in-non-small-cell-lung-cancer-by-targeting-sox9-%C3%AE-catenin-axis
#38
JOURNAL ARTICLE
Munmun Panda, Stuti Biswal, Bijesh K Biswal
BACKGROUND: In recent decades, phytotherapy has remained as a key therapeutic option for the treatment of various cancers. Evodiamine, an excellent phytocompound from Evodia fructus, exerts anticancer activity in several cancers by modulating drug resistance. However, the role of evodiamine in cisplatin-resistant NSCLC cells is not clear till now. Therefore, we have used evodiamine as a chemosensitizer to overcome cisplatin resistance in NSCLC. METHODS: Here, we looked into SOX9 expression and how it affects the cisplatin sensitivity of cisplatin-resistant NSCLC cells...
April 17, 2024: Molecular Biology Reports
https://read.qxmd.com/read/38630148/utilization-of-sperm-cryopreservation-in-patients-with-testicular-cancer
#39
JOURNAL ARTICLE
Viktoria Menzel, Emilia Richter, Charlotte Helke, Björn Thorben Bürk, Holger H H Erb, Steffen Leike, Angelika Borkowetz, Christian Thomas, Martin Baunacke
PURPOSE: We assessed factors that affect the utilization of sperm cryopreservation before 2021, when patients covered expenses, and the influence on quality of life. METHODS: Between 2011 and 2021, testicular cancer survivors (TCS) at our clinic completed a questionnaire, including EORTC QLQ-TC26, covering sperm cryopreservation, sociodemographic details, post-treatment births, and artificial insemination. RESULTS: After 5.7 ± 3...
April 17, 2024: Journal of Cancer Research and Clinical Oncology
https://read.qxmd.com/read/38630146/fragile-hands-targeting-nonmelanoma-skin-cancer-on-older-hands-using-595%C3%A2-nm-pulsed-dye-laser
#40
JOURNAL ARTICLE
Elliott D Herron, Ashley M Snyder, Christopher M Hull, Steven LoBello, Mark D Herron
PURPOSE: The mainstay of treatment for nonmelanoma skin cancer (NMSC) on thin skin remains surgical, but procedures on older hands may be complicated by skin fragility and dermal atrophy. Used without cooling, 595 nm (nm) pulsed dye laser (PDL) has the capability of destroying NMSC through nonspecific thermal necrosis. The purpose of this study was to understand recurrence of NMSC on dorsal hands of older patients after one or two treatments using 595 nm PDL. METHODS: A retrospective chart review identified 147 cases of NMSC located on the dorsal hands treated with 595 nm PDL...
April 17, 2024: Lasers in Medical Science
keyword
keyword
52952
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.